Group Vice President, General Manager of Rare Diseases Division
Xiao Li graduated from school of medicine, Wuhan University in 1997 and then worked as a stomatologist in Suzhou Municipal Hospital.
In 2000, she joined pharmaceutical industry. She worked for several multinational companies including Xi’an Janssen, Bristol-Myers Squibb, Sanofi, etc., and served in the diversified positions covering product manager, regional manager, marketing manager, marketing director, and strategic portfolio development director. In the past 21 years, Miss Xiao accumulated rich commercialization experiences and had excellent track records in the pharmaceutical industry through comprehensive products at different life cycle stages in multiple therapeutic areas.
During the period she worked in Sanofi, she successfully accelerated the launch of blockbuster Dupixent, and commercialization progress of several rare disease products such as Fabrazyme and Aldurazyme in China.